Moreover, previous studies have reported that paclitaxel is an excellent P-glycoprotein (ABCB1) substrate [26, 27], and that multidrug resistance-associated protein 7 (MRP7/ABCC10) expression is a predictive biomarker for the resistance to paclitaxel in various types of cancer cells [28–30]. Here, ABCB1 is linked to cancer.